Lansen Pharmaceutical Holdings Limited (0503.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
652
First IPO Date
May 07, 2010
| Name | Title | Pay | Year Born |
| Li Chen | Executive MD, Chief Executive Officer & Executive Director | 5.96M | 1962 |
| Hua Li | Head of Finance Management Centre | 0 | 1985 |
| Jianshe Nan | Head of Business Development | 0 | 1966 |
| Kai Fai Pang | Finance Manager & Company Secretary | 0 | N/A |
| Yu Zhao | Group Human Resources Director | 0 | 1973 |
Lansen Pharmaceutical Holdings Limited, an investment holding company, concentrates on the research, manufacturing, and global distribution of niche pharmaceutical drugs. These specialized medicines primarily address conditions in rheumatology and dermatology, serving both the People's Republic of China and international markets. The company's business operations are organized into three distinct divisions: Pharmaceuticals, Cosmetic Products, and Healthcare Products. Its product range includes generic traditional Chinese medicines, various cosmetic goods, and health-related items. Established in 2001, its main offices are situated in Ningbo, China. Lansen Pharmaceutical Holdings Limited operates as a subsidiary of Cathay International Pharma Manufacture and Distribution (China) Limited.